Which steroid sparing therapies are used in Giant Cell Arteritis

Which steroid sparing therapies are used in Giant Cell Arteritis?

Methotrexate has long been used as a steroid-sparing therapy in GCA, although evidence supporting its use is mixed with regard to its effectiveness. Nonetheless, methotrexate is utilized in patients with significant steroid-related side effects, diabetes, or a relapsing course with prolonged need for steroids. Based on randomized clinical trial data ( GiACTA ), tocilizumab was recently granted a Food and Drug Administration (FDA) indication for GCA treatment (the only medication with such an indication).

15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856